[Elsevier] Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study |
|
This post will be closed automatically in 2026-07-30 06:29
Best Answer
1 hour(s) ago
|
| |
post
reply
points
0
10
CompactAid: Minimizing the complexity and improving the accuracy of medical segmentation algorithms through a novel spatial and channel attention mechanism
10
First principles and molecular dynamics insights into thermally stable aluminum-based perovskite hydrides for hydrogen storage applications
10
[Supplementary]Bagasse based biochar for the adsorptive removal of chlorpyrifos from contaminated water
10
Peptide-based co-assembling materials: bridging fundamental science and versatile applications
10
Enhancing the neutronic performance of SMART Small modular reactor using alternative fuel material
